Intranasal Delivery

Absorption depends partly on how long a formulation remains at the nasal mucosa and how readily it crosses the epithelial tissue. Mucociliary clearance can remove deposited material before absorption, whereas tissue permeability affects movement into underlying tissues and, potentially, the circulation. Formulation properties also influence dissolution and the amount of agent available for uptake.

The site of deposition allows a formulation to act within the nasal region or to cross the mucosal epithelium for broader distribution. Once dissolved in nasal secretions, the agent may enter pathways that support systemic exposure without first passing through the gastrointestinal tract. This makes the route relevant to therapies targeting either nasal conditions or effects elsewhere in the body.

Central nervous system access remains an area of research rather than a guaranteed outcome. Investigations examine how deposition, dissolution, epithelial passage, mucociliary clearance, and formulation properties affect movement beyond the nasal site. These factors help determine whether a therapeutic agent can be directed toward the central nervous system and whether that approach improves treatment potential.

A typical sequence begins with deposition on the nasal mucosa, followed by dissolution in nasal secretions. The dissolved agent then encounters the mucosal epithelium, where tissue permeability and formulation characteristics influence absorption. At the same time, mucociliary clearance may remove material from the site, so the balance between retention, dissolution, and uptake affects the resulting distribution.

This route may be considered for treatment of nasal and respiratory conditions, or when a selected therapy could benefit from systemic exposure without gastrointestinal degradation. Its noninvasive nature also makes it relevant when avoiding injections may support patient acceptance or adherence. Suitability depends on how the agent behaves at the nasal mucosa and where treatment is intended to act.

Studies may examine local effects in the nasal or respiratory tissues, systemic distribution after mucosal absorption, and the possibility of directing agents toward the central nervous system. Researchers also assess how clearance, permeability, and formulation properties shape these outcomes. In clinical medicine, the route is additionally considered for its potential to provide a more convenient alternative to injections for selected therapies.